Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/05/2018
Entire Document
 


Case 18-10518-KG    Doc 446    Filed 06/29/18    Page 5 of 11

 

In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: May 1, 2018 - May 31, 2018

 

MOR - 1a

Schedule of Disbursements by Debtor Entity (1)

For the Period: May 1, 2018 - May 31, 2018

(Unaudited)

 

$ USD ‘000s

Debtor

   May 1, 2018 - May 31, 2018      Cumulative
Since Filing
 

Orexigen Therapeutics, Inc.

   $ 14,402      $ 46,052  
  

 

 

    

 

 

 

Total

   $ 14,402      $ 46,052  

Notes:

 

(1) The Schedule of Disbursements is presented on a book basis.